Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 193.2 | 137.7 | 93.5 | 70.6 |
| Revenue growth | 40.4% | 47.3% | 32.4% | |
| Cost of goods sold | 53.3 | 31.8 | 21.4 | 20.5 |
| Gross profit | 140.0 | 105.9 | 72.1 | 50.1 |
| Gross margin | 72.4% | 76.9% | 77.1% | 70.9% |
| Sales and marketing | 122.6 | 93.8 | 53.7 | 38.9 |
| Research and development | 59.9 | 44.4 | 22.1 | 16.2 |
| General and administrative | 45.3 | 33.8 | 16.0 | 11.0 |
| EBITA | -83.3 | -65.5 | -19.7 | -16.1 |
| EBITA margin | -43.1% | -47.6% | -21.0% | -22.8% |
| Amortization of intangibles | 4.6 | 0.6 | | |
| EBIT | -87.9 | -66.1 | -19.7 | -16.1 |
| EBIT margin | -45.5% | -48.0% | -21.0% | -22.8% |
| Pre-tax income | -83.1 | -68.0 | -21.4 | -17.2 |
| Income taxes | 0.5 | 1.0 | 0.6 | 0.5 |
| Net income | -83.7 | -69.0 | -22.0 | -17.7 |
| Net margin | -43.3% | -50.1% | -23.5% | -25.1% |
| |
| Diluted EPS | ($1.10) | ($1.30) | ($1.52) | ($1.32) |
| Shares outstanding (diluted) | 75.7 | 53.2 | 14.4 | 13.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|